Today: 21 May 2026
Browse Category

NASDAQ:INTU 9 February 2026 - 20 May 2026

Intuit’s Q3 Numbers Land as Shares Down 39%

Intuit’s Q3 Numbers Land as Shares Down 39%

Intuit will report fiscal third-quarter results after U.S. markets close Wednesday, following a 39% stock drop over the past year. Analysts expect earnings of $12.57 per share on $8.54 billion revenue, both up from last year. The quarter covers peak tax season for TurboTax and QuickBooks. Intuit shares closed at $399.71 Tuesday, down 0.9%.
20 May 2026
··
Nasdaq slips as Wall Street rally faces yield jolt

Nasdaq slips as Wall Street rally faces yield jolt

U.S. stocks fell Tuesday morning, with the Nasdaq down 1.05% and the S&P 500 off 0.69%, as rising Treasury yields and firm oil prices pressured markets. The U.S. 10-year yield neared 4.61%, while Brent crude traded at $110.67 a barrel. Materials and consumer discretionary sectors led declines. Investors await Nvidia’s earnings and Federal Reserve minutes due Wednesday.
19 May 2026
······
Anthropic Launches Claude for Small Business to Take On Payroll, Invoices and Marketing

Anthropic Launches Claude for Small Business to Take On Payroll, Invoices and Marketing

Anthropic launched Claude for Small Business on Wednesday, integrating its AI assistant with apps like QuickBooks, PayPal, HubSpot, and Canva. The product offers 15 preset workflows and skills for tasks such as payroll, invoicing, and campaign management. U.S. small businesses number 36.2 million and employ 62.3 million people, according to the SBA. PayPal and Canva are among launch partners.
13 May 2026
······
Intuit Inc. Expands Credit Karma and QuickBooks AI Push as INTU Stock Slips

Intuit Inc. Expands Credit Karma and QuickBooks AI Push as INTU Stock Slips

Intuit’s Credit Karma opened its platform to Americans with no credit history, targeting about 17 million “credit invisible” adults. Shares fell 4.4% to $388.85 Friday morning after the move and the launch of a new QuickBooks workforce product. Intuit reports fiscal Q3 results May 20, following a quarter that included the peak U.S. tax season.
8 May 2026
···
Intuit Stock Rebounds After AI Selloff as TurboTax Owner Nears Earnings Test

Intuit Stock Rebounds After AI Selloff as TurboTax Owner Nears Earnings Test

Intuit shares rose 3.3% to $395.95 on Friday, recovering part of Thursday’s AI-driven losses. The company’s fiscal third-quarter results, covering the peak U.S. tax season, are due after April 30. Investors are watching TurboTax and QuickBooks growth as AI competition pressures software valuations. Intuit forecasts about 10% revenue growth and non-GAAP EPS of $12.45 to $12.51 for the quarter.
25 April 2026
···
Intuit stock jumps to $409 after earnings — what matters before Monday’s open (INTU)

Intuit stock jumps to $409 after earnings — what matters before Monday’s open (INTU)

Intuit shares rose 3.7% to $409.03 Friday on heavy volume, then dropped about 4% after hours following a third-quarter profit forecast below Wall Street estimates. The company reported second-quarter revenue up 17% to $4.651 billion and raised its quarterly dividend to $1.20 per share. CFO Sandeep Aujla said higher spending targets growth in assisted tax and QuickBooks.
28 February 2026
··
Intuit stock drops after hours as TurboTax maker flags heavier tax-season spending

Intuit stock drops after hours as TurboTax maker flags heavier tax-season spending

Intuit shares dropped 5.3% to $373.48 in after-hours trading Thursday after forecasting third-quarter profit below Wall Street estimates. The company cited increased marketing and support spending to compete in assisted tax and QuickBooks. Earlier, the stock closed up 3.46% at $394.42. Intuit reported second-quarter revenue of $4.65 billion, up 17%, and raised its quarterly dividend 15%.
27 February 2026
·
Intuit stock jumps today as Anthropic AI tie-up puts earnings in focus

Intuit stock jumps today as Anthropic AI tie-up puts earnings in focus

Intuit shares jumped 4.2% to $397.21 by late morning Thursday, ahead of its fiscal Q2 earnings report after the bell. The stock extended Wednesday’s rally, trading between $387.96 and $406.46. Investors are watching for updates on AI partnerships with Anthropic and signs of tax-season demand at TurboTax. CEO Sasan Goodarzi is scheduled to speak at a Morgan Stanley conference March 2.
26 February 2026
···
Intuit stock price jumps on Anthropic AI deal as earnings loom — what investors watch Thursday

Intuit stock price jumps on Anthropic AI deal as earnings loom — what investors watch Thursday

Intuit shares rose 6.3% to $381.23 on Wednesday after announcing a multi-year AI partnership with Anthropic. The stock remains down 46% year-to-date amid a broader software selloff. Wells Fargo cut its price target to $425 from $700. Investors await Intuit’s earnings report Thursday for signs of AI-driven demand.
26 February 2026
···
Intuit stock price slips today after analyst target cuts; Mailchimp ecommerce push in focus

Intuit stock price slips today after analyst target cuts; Mailchimp ecommerce push in focus

Intuit shares fell 0.7% to $434.58 Tuesday, trading between $429.22 and $450.99 as BMO and TD Cowen cut price targets but kept positive ratings. Analysts cited tax-season trends and AI risks. Investors are watching Mailchimp’s new ecommerce tools and upcoming quarterly results for signs of demand. Thirty-day implied volatility in software stocks stayed elevated.
10 February 2026
·
Intuit stock drops in afternoon trade as TD Cowen cuts target and AI jitters linger

Intuit stock drops in afternoon trade as TD Cowen cuts target and AI jitters linger

Intuit shares fell 1.3% to $438.01 Monday, underperforming a 2.4% gain in the broader software sector. TD Cowen cut its price target to $658, citing AI concerns, while Jefferies maintained an $850 target, calling AI fears “too harsh.” The stock traded between $431.53 and $447.00. Investors are watching for Intuit’s quarterly results on Feb. 26.
9 February 2026
··
1 2 3 … 6

Stock Market Today

  • Coca-Cola and Beverage Sector Show Mixed Q1 Performance with Vita Coco Leading Gains
    May 20, 2026, 9:22 PM EDT. As Q1 earnings wrap up, beverages, alcohol, and tobacco stocks report mixed results. The sector beat revenue estimates by 4.9%, though next-quarter guidance fell short by 0.6%. Coca-Cola (NYSE:KO) posted strong growth with $12.47 billion in revenue, exceeding estimates by 2.5%, and shares rose 7.7%. Leading the pack was Vita Coco (NASDAQ:COCO), with a 37.3% revenue surge and a 54.1% stock gain post-earnings. In contrast, Boston Beer (NYSE:SAM) saw a 4.4% revenue decline and missed on operating income forecasts, marking the weakest performance among peers. Shifting consumer trends and social media-driven lower brand launch costs are reshaping competition in the sector.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop